Latest news from the Science Center, the companies we support and the innovation ecosystem.
April 12, 2019 | Science Center In The News
BioArt: Where Art and Bioengineering Intersect
BioArt is a growing field in contemporary art and a crucial one to maintain critical engagement with the kind of bioengineering that is transforming humanity’s ability to sustain larger populations and ultimately change and shape who we are as a species. Some artists like Heather Dewey-Hagborg, for example, have explored how histories of power, race, and incarceration, are being rewritten into the nascent fields of genetic surveillance.
University start-ups gain global reach without leaving home
Start-up companies that want to do business internationally often find themselves in a Catch-22. They know they must build contacts in overseas markets, but they don’t have time or money to travel the world. Yet strong international contacts could be the fuel that pushes some start-ups over the edge to long-term success.
The University City Science Center’s purpose is to make the world a better place by freeing great ideas from the confines of the laboratory, and moving promising research to the next stage on the pathway to commercialization.
Those great ideas could be the next treatments or cures for rare diseases, or technologies that can improve our quality of life in various ways. They move along the commercialization pathway thanks to the work of entrepreneurs, many of whom are affiliated with academic research institutions. But they are unable to come to fruition without adequate resources and support.
The West Philadelphia school has landed prestigious R1 status, the highest level a research university can reach in a key higher education classification system.
As a result, Philadelphia’s now home to three top-tier research institutions — joining the University of Pennsylvania and Temple University, which reached R1 status in 2016 — and that’s big news for the region’s innovation-driven economy.
Temple medical school awarded grant for brain injury research
Researchers from the Lewis Katz School of Medicine and other medical professionals in Philadelphia institutions received a $700,000 grant to research traumatic brain injuries.
Part of the grant from The Science Center, a nonprofit that supports technological advancement, was awarded to Servio Ramirez, a Temple University pathology and laboratory medicine professor, and his team of researchers from the Katz School of Medicine, who are developing ways to detect and diagnose TBI through the bloodstream. The Children’s Hospital of Philadelphia, University of Delaware and the University of Pennsylvania will also receive part of the combined award.
N.J. biotech firm expanding to Philadelphia, creating 200 new jobs
In another boost to Philadelphia’s standing as a cell and gene therapy hub, Cranbury, New Jersey-based Amicus Therapeutics said Tuesday it is establishing a new global research and gene therapy center at uCity Square, where the company expects to have 200 employees over the next few years.
Gene therapy innovators Amicus Therapeutics to join University City's surging biotech sector
Amicus Therapeutics, a growing biopharmaceutical company that focuses on rare and orphan diseases, is committing to Philadelphia in a big way.
Citing the city as a burgeoning hub for medical breakthroughs, Amicus will launch a new Global Research and Gene Therapy Center at uCitySquare.